Energy Profile and Low Intensity Activity (PROFILE)
PROFILE
Energy Adaptations During Active Workstation Use: Strategy for Individualization of Active Desk Programs
2 other identifiers
interventional
50
1 country
1
Brief Summary
The recent literature has highlighting the importance of the time of SB and the level of physical activity (PA) as predictors of metabolic cardio risks. Now, sedentary lifestyles are well recognized as one of the causes of mortality. As with physical activity, a dose-response relationship appears to exist: mortality would increase with time spent in sedentary behaviors. However, this relationship would not be linear: the more the daily sitting time increases, the more the consequences on mortality are important. It is now well demonstrated that time spent in sedentary adult behaviour finds primarily its origin in the work, characterized by prolonged and uninterrupted periods of sitting. Many strategies have been settled to break the prolonged sitting time. The most promising one seem to be the use of active workstations (standing, walking, cycling, stepping) because they reduce sedentary time at work and increase physical activity with positive effects on the global health. However inter variability in energy response have been identified during a sit to stand allocation with subject "savers" profile showing an increase in energy expenditure while others categorized as "non-savers" increased significantly their energy expenditure between sitting and standing position. As others active workstation strategies exist, this study aim to first, better characterize energy response to posture and activity allocation (15min sit-15min stand-15min sit-15min low intensity cycling), secondly to identify parameters that could explain different energy profile.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable healthy
Started May 2021
Longer than P75 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 9, 2021
CompletedFirst Posted
Study publicly available on registry
April 28, 2021
CompletedStudy Start
First participant enrolled
May 25, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 12, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 29, 2023
CompletedJuly 10, 2023
July 1, 2023
1.6 years
April 9, 2021
July 7, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
energy expenditure
Using an indirect calorimetry device change in energy expenditure will be assed during the 1h posture /activity allocation (15min sitting, 15min standing, 15min sitting, 15 min low intensity cycling)
change from baseline to the experimental visit (Day 1)
Secondary Outcomes (8)
physical activity level (ActiGraph)
during the 7 days following the experimental session
physical activity level (ActivPAL)
during the 7 days following the experimental session
Body composition : fat mass and fat free mass
day 0
upper limb strength
during the experimental session after energy expenditure assessment (Day 1)
aerobic fitness
during the experimental session after energy expenditure assessment (day 1)
- +3 more secondary outcomes
Study Arms (1)
Healthy volunteer
EXPERIMENTALInterventions
15min sitting, 15min standing, 15min sitting, 15 min low intensity cycling
Eligibility Criteria
You may qualify if:
- Healthy volunteer, male or female, between 18 and 61 years old
- Body mass index \> 18,5 kg/m2 and ≤ 25 kg/m2
- Able to provide informed consent to research participation
- Registered in the French social security system
You may not qualify if:
- Subject using a sit-to-stand office desk or a swiss ball
- Contact jobs (face-to-face with people)
- Pregnant or breastfeeding women
- Medical or surgical history determined by principal investigator to be not compatible with the study
- Subject with cardiorespiratory and/or osteo-articular disorders limiting their ability to perform physical tests or the use of active offices
- Subject with type 1 or type 2 diabetes treated with insulin
- Subject with progressive cardiovascular or neoplastic disease.
- Subject with known neuromuscular pathology: myopathy, myasthenia, rhabdomyolysis, paraplegia, hemiplegia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Clermont-Ferrandlead
- Laboratory AME2P UR3533collaborator
- Université d'Auvergnecollaborator
Study Sites (1)
CHU de Clermont-Ferrand
Clermont-Ferrand, 63000, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Martine Duclos
University Hospital, Clermont-Ferrand
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 9, 2021
First Posted
April 28, 2021
Study Start
May 25, 2021
Primary Completion
December 12, 2022
Study Completion
June 29, 2023
Last Updated
July 10, 2023
Record last verified: 2023-07